These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 33396625)
1. S-Adenosylmethionine Inhibits Cell Growth and Migration of Triple Negative Breast Cancer Cells through Upregulating MiRNA-34c and MiRNA-449a. Coppola A; Ilisso CP; Stellavato A; Schiraldi C; Caraglia M; Mosca L; Cacciapuoti G; Porcelli M Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396625 [TBL] [Abstract][Full Text] [Related]
2. S-Adenosylmethionine Inhibits Colorectal Cancer Cell Migration through Mirna-Mediated Targeting of Notch Signaling Pathway. Borzacchiello L; Veglia Tranchese R; Grillo R; Arpino R; Mosca L; Cacciapuoti G; Porcelli M Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887021 [TBL] [Abstract][Full Text] [Related]
3. S-Adenosylmethionine regulates apoptosis and autophagy in MCF-7 breast cancer cells through the modulation of specific microRNAs. Ilisso CP; Delle Cave D; Mosca L; Pagano M; Coppola A; Mele L; Caraglia M; Cacciapuoti G; Porcelli M Cancer Cell Int; 2018; 18():197. PubMed ID: 30533999 [TBL] [Abstract][Full Text] [Related]
4. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells. Wu J; Li WZ; Huang ML; Wei HL; Wang T; Fan J; Li NL; Ling R Biochem Biophys Res Commun; 2017 Jan; 483(1):10-16. PubMed ID: 28069384 [TBL] [Abstract][Full Text] [Related]
5. Tamoxifen reverses epithelial-mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells. Wang Q; Cheng Y; Wang Y; Fan Y; Li C; Zhang Y; Wang Y; Dong Q; Ma Y; Teng YE; Qu X; Liu Y BMC Cancer; 2017 Jul; 17(1):492. PubMed ID: 28724364 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24. Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450 [TBL] [Abstract][Full Text] [Related]
7. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer. Liu S; Wang Z; Liu Z; Shi S; Zhang Z; Zhang J; Lin H J Mol Cell Biol; 2018 Aug; 10(4):302-315. PubMed ID: 30053090 [TBL] [Abstract][Full Text] [Related]
8. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression. Guo GC; Wang JX; Han ML; Zhang LP; Li L Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis. Xu W; Song C; Wang X; Li Y; Bai X; Liang X; Wu J; Liu J Aging (Albany NY); 2021 Jan; 13(1):228-240. PubMed ID: 33472170 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator. Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250 [TBL] [Abstract][Full Text] [Related]
11. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients. Li YY; Zheng XH; Deng AP; Wang Y; Liu J; Zhou Q; Cheng GY; Jiang Q Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10433-10442. PubMed ID: 31841197 [TBL] [Abstract][Full Text] [Related]
12. Wnt pathway targeting reduces triple-negative breast cancer aggressiveness through miRNA regulation in vitro and in vivo. Mohammadi-Yeganeh S; Hosseini V; Paryan M J Cell Physiol; 2019 Aug; 234(10):18317-18328. PubMed ID: 30945294 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of the miR-141/200c cluster promotes the migratory and invasive ability of triple-negative breast cancer cells through the activation of the FAK and PI3K/AKT signaling pathways by secreting VEGF-A. Choi SK; Kim HS; Jin T; Hwang EH; Jung M; Moon WK BMC Cancer; 2016 Aug; 16():570. PubMed ID: 27484639 [TBL] [Abstract][Full Text] [Related]
14. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331 [TBL] [Abstract][Full Text] [Related]
15. Induced expression of miR-1250-5p exerts tumor suppressive role in triple-negative breast cancer cells. Shuaib M; Kumar S J Cell Biochem; 2023 Feb; 124(2):282-293. PubMed ID: 36548440 [TBL] [Abstract][Full Text] [Related]
16. miR-506-loaded gelatin nanospheres target PENK and inactivate the ERK/Fos signaling pathway to suppress triple-negative breast cancer aggressiveness. Liu XL; Liu WJ; Chen Q; Liu J; Yang CQ; Zhang G; Zhang SL; Guo WH; Li JB; Zhao G; Yin DC; Zhang CY Mol Carcinog; 2021 Aug; 60(8):538-555. PubMed ID: 34062009 [TBL] [Abstract][Full Text] [Related]
17. Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells. Al-Othman N; Hammad H; Ahram M Gene; 2018 Oct; 675():128-135. PubMed ID: 29964098 [TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer. Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586 [TBL] [Abstract][Full Text] [Related]
19. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer. Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1. Chen LL; Zhang ZJ; Yi ZB; Li JJ Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]